Roche

Roche

Verified
Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$199.0b (Public information from Jun 2024)
Company register number CHE-105.815.381
Basel Canton of Basel-Stadt (HQ)
Corporate Venture Fund: Roche Venture Fund

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
CHF2020202120222023202420252026
Revenues0000000000000000000000000000
% growth(5 %)8 %1 %(4 %)(1 %)6 %4 %
EBITDA0000000000000000000000000000
% EBITDA margin39 %36 %34 %31 %38 %38 %39 %
Profit0000000000000000000000000000
% profit margin25 %22 %20 %19 %22 %23 %24 %
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue22 %24 %25 %23 %---

Source: Dealroom estimates

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
*
N/A

$5.5b

Post IPO Debt
Total Funding000k

Recent News about Roche

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Roche

Edit
MySugr
ACQUISITION by Roche Jun 2017
Spark Therapeutics
ACQUISITION by Roche Feb 2019
Ignyta
ACQUISITION by Roche Dec 2017
Tensha Therapeutics
ACQUISITION by Roche Jan 2016
Arius Research
ACQUISITION by Roche Jul 2008
Flatiron Health
ACQUISITION by Roche Venture Fund Feb 2018
Carmot Therapeutics
ACQUISITION by Roche Dec 2023
Trophos
ACQUISITION by Roche Jan 2015
Santaris Pharma
ACQUISITION by Roche Aug 2014
View 58 more

Roche events

Edit